These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1053)

  • 21. Acid resistant lipase as replacement therapy in chronic pancreatic exocrine insufficiency: a study in dogs.
    Griffin SM; Alderson D; Farndon JR
    Gut; 1989 Jul; 30(7):1012-5. PubMed ID: 2759481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Substitution management of exocrine pancreatic insufficiency with a fungal lipase].
    Löffler A; Wisskirchen KJ; Kutz K
    Ther Ggw; 1976 Mar; 115(3):439-46. PubMed ID: 772867
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic effects of an activated pancreatic extract in digestive insufficiency].
    Fontana G; Gandolfi L; Scaletti GC; Govi D
    Minerva Med; 1972 May; 63(36):2059-74. PubMed ID: 5030692
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of exocrine pancreatic insufficiency: what gastroprotection do pancreatic enzymes provide?].
    Zylberberg P; Delchier JC
    Gastroenterol Clin Biol; 1993; 17(11):816-22. PubMed ID: 8143947
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of pancreatic exocrine insufficiency. I. In vitro lipolytic activities of pancreatic lipase and fifteen commercial pancreatic supplements.
    Giulian BB; Lokendra BA; Singh LM; Mansfield AO; Pairent FW; Howard JM
    Ann Surg; 1967 Apr; 165(4):564-70. PubMed ID: 6021457
    [No Abstract]   [Full Text] [Related]  

  • 27. Lipase supplementation therapy: standards, alternatives, and perspectives.
    Layer P; Keller J
    Pancreas; 2003 Jan; 26(1):1-7. PubMed ID: 12499909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exocrine pancreatic insufficiency in celiac sprue: a cause of treatment failure.
    Regan PT; DiMagno EP
    Gastroenterology; 1980 Mar; 78(3):484-7. PubMed ID: 7351287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic extracts in the treatment of pancreatic exocrine insufficiency.
    Saunders JH; Wormsley KG
    Gut; 1975 Feb; 16(2):157-62. PubMed ID: 236213
    [No Abstract]   [Full Text] [Related]  

  • 30. [The significance of the evocative test in the diagnosis of chronic pancreatitis (author's transl)].
    Sommer H; Kasper H; Fleischer K
    Med Klin; 1978 Jul; 73(28-29):1051-5. PubMed ID: 672758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An enteric-coated pancreatic enzyme preparation that works.
    Graham DY
    Dig Dis Sci; 1979 Dec; 24(12):906-9. PubMed ID: 510089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic exocrine insufficiency following pancreatic resection.
    Ghaneh P; Neoptolemos JP
    Digestion; 1999; 60 Suppl 1():104-10. PubMed ID: 10026442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
    Löser C; Fölsch UR
    Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
    Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
    Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of pancreatic exocrine insufficiency after pancreatic resection. Results of a randomized, double-blind, placebo-controlled, crossover study of high vs standard dose pancreatin.
    Neoptolemos JP; Ghaneh P; Andrén-Sandberg A; Bramhall S; Patankar R; Kleibeuker JH; Johnson CD
    Int J Pancreatol; 1999 Jun; 25(3):171-80. PubMed ID: 10453419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Enzyme preparations in conservative treatment of chronic pancreatitis].
    Okhlobystin AV; Bayarmaa N
    Ter Arkh; 1998; 70(10):86-8. PubMed ID: 9864814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal fat concentration in the differential diagnosis of steatorrhea.
    Bai JC; Andrüsh A; Matelo G; Martinez C; Vazquez H; Boerr L; Sambuelli A
    Am J Gastroenterol; 1989 Jan; 84(1):27-30. PubMed ID: 2912027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sense and nonsense in the treatment of exocrine pancreatic insufficiency].
    Mössner J
    Schweiz Rundsch Med Prax; 1994 Aug; 83(32):873-6. PubMed ID: 8091057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality of life assessment after pancreatic enzyme replacement therapy in chronic pancreatitis.
    Czakó L; Takács T; Hegyi P; Prónai L; Tulassay Z; Lakner L; Döbrönte Z; Boda K; Lonovics J
    Can J Gastroenterol; 2003 Oct; 17(10):597-603. PubMed ID: 14571298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.